TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: A phase Ib/IIa trial in patients with R/R CD30+ T-cell lymphoma with cutaneous presentation in 15 patients, including 5 with a PTCL variant, reported a poster at ASH 2020.